nach oben

Heart and Vessels

Erschienen in:

20.08.2015 | Original Article

Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients

verfasst von: Altaf Afrasyab, Peng Qu, Yang Zhao, Kuang Peng, Hongyan Wang, Dayuan Lou, Nan Niu, Dajun Yuan

Erschienen in: Heart and Vessels | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

We decided to assess the prognostic value of NLRP3 inflammasome level in acute coronary syndrome (ACS) patients and whether it was related to coronary atherosclerotic severity. Study population included one-hundred and twenty-three (123) subjects. Peripheral blood monocyte NLRP3 protein level was correlated with clinical presentation, angiographic characteristics and its scoring systems as well as GRACE and TIMI risk scores. Follow-up for major adverse cardiac events (MACE) was carried out at 180 days. Peripheral blood monocyte NLRP3 was found to be elevated in ACS patients (P < 0.05) and showed positive correlation with GRACE score (r = 0.619), TIMI score (r = 0.580), SYNTAX score (r = 0.550), Clinical SYNTAX score (r = 0.564) and Gensini score (r = 0.516). NLRP3 was also increased with increasing number of vessels, the number of lesions present and the presence bifurcation lesions (P < 0.05). Multivariate Cox regression analysis showed NLRP3 to be an independent predictor of MACE (P = 0.043). Kaplan–Meier analysis and receiver operating characteristic curves for NLRP3 showed good predictive value for MACE. There is a positive correlation of NLRP3 level with severity of coronary atherosclerosis. NLRP3 level is a promising prognostic utility and is efficient in event prediction for MACE.

Katritsis D, Korovesis S, Giazitzoglou E, Parissis J, Kalivas P, Webb-Peploe MM, Ioannidis JP, Haliassos A (2001) C-reactive protein concentrations and angiographic characteristics of coronary lesions. Clin Chem 47(5):882–886PubMed

Rajamaki K, Lappalainen J (2010) Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 5:e11765CrossRefPubMedPubMedCentral

Coll RC, O’Neill LA (2010) New insights into the regulation of signalling by toll-like receptors and nod-like receptors. J Innate Immun 2:406–421CrossRefPubMed

Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Dangas G, Lazar D, Sanchez R, Fahy M, Xu K, Stone GW (2011) Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention. J Am Coll Cardiol 57(24):2389–2397CrossRefPubMed

Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C, Tamburino C (2009) Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv 2(4):302–308CrossRefPubMed

Kim YH, Park DW, Kim WJ, Lee JY, Yun SC, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ (2010) Validation of SYNTAX (synergy between PCI with taxus and cardiac surgery) score for prediction of outcomes after unprotected left main coronary revascularization. JACC Cardiovasc Interv 3(6):612–623CrossRefPubMed

Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Rademaker T, Wittebols K, Stoll HP, Investigators ARTSII (2010) 5-year clinical outcomes of the ARTS II (arterial revascularization therapies study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 55(11):1093–1101CrossRefPubMed

van Gaal WJ, Ponnuthurai FA, Selvanayagam J, Testa L, Porto I, Neubauer S, Banning AP (2009) The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol 135(1):60–65CrossRefPubMed

Wykrzykowska JJ, Garg S, Girasis C, Vries TD, More MA, GAV ES, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, Mario CD, Geuns RJV, Juni P, Windecker S, Serruys PW (2010) Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial. JACC 56(4):272–277CrossRefPubMed

10.

Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention 1(2):219–227PubMed

11.

Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T, Morice MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, Morel MA, Mohr FW (2009) Assessment of the SYNTAX score in the Syntax study. Eurointervention 5(1):50–56CrossRefPubMed

12.

Kato S, Saito N, Kirigaya H, Gyotoku D, Iinuma N, Kusakawa Y, Iguchi K, Nakachi T, Fukui K, Futaki M, Iwasawa T, Taguri M, Kimura K, Umemura S (2015) Incremental prognostic value of the SYNTAX score to late gadolinium-enhanced magnetic resonance images for patients with stable coronary artery disease. Heart Vessels. doi:10.1007/s00380-015-0685-x

13.

Gensini GG (1983) A more meaningful scoring system for deter-mining the severity of coronary heart disease. Am J Cardiol 51(3):606CrossRefPubMed

14.

Garg S, Sarno G, Garcia-Garcia HM, Girasis C, Wykrzykowska J, Dawkins KD, Serruys PW, Investigators ARTS-II (2010) A new tool for the risk stratification of patients with complex coronary artery disease: the clinical SYNTAX score. Circ Cardiovasc Interv 3(4):317–326CrossRefPubMed

15.

Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G (2009) Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation 119(24):3053–3061CrossRefPubMed

16.

Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the,2002Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine Circulation 116 (7):e148–e148

17.

Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, Fox KA, Hasdai D, Ohman EM, Wallentin L, Wijns W (2007) Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the european society of cardiology. Eur Heart J 28(13):1598–1660CrossRef

18.

Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, De Van, Werf F, Avezum A, Goodman SG, Flather MD, Fox KA (2003) Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163(19):2345–2353CrossRefPubMed

19.

Ramsay G, Podogrodzka M, Mcclure C, Fox KA (2007) Risk prediction in patients presenting with suspected cardiac pain: the GRACE and TIMI risk scores versus clinical evaluation. Q J M 100(1):11–18CrossRef

20.

Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE 3rd, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC Jr, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) (2002) ACC/AHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction-2002: Summary Article: A report of the AmericanCollege of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation 106(14):1893–1900CrossRefPubMed

21.

Davies JQ, Gordon S (2005) Isolation and culture of human macrophages. Methods Mol Biol 290:105–116PubMed

22.

Margolis JR, Gillum RF, Feinleib M, Brasch RC, Fabsitz RR (1974) Community surveillance for coronary heart disease: the Framingham cardiovascular disease survey Methods and preliminary results. Am J Epidemoil 100(6):425–436

23.

Rifai N, Joubran R, Yu H, Jouma M (1999) Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem 45(11):1967–1973PubMed

24.

Zheng F, Xing S, Gong Z, Xing Q (2013) NLRP3 inflammasomes show high expression in aorta of patients with atherosclerosis. Heart Lung Circ. 22(9):746–750CrossRefPubMed

25.

Satoh M, Tabuchi T, Itoh T, Nakamura M (2014) NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin. Clin Sci 126(3):233–241CrossRefPubMed

26.

Xian WC, Zhe H, Masafumi K, Kenji O, Toyoaki M (2011) Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications. Hypertension 58:978–986CrossRef

27.

Cassel SL, Joly S (2009) The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol 21:194–198CrossRefPubMedPubMedCentral

28.

Kawamura A, Baitsch D, Telgmann R, Feuerborn R, Weissen-Plenz G, Hagedorn C, Saku K, Brand-Herrmann SM, von Eckardstein A, Assmann G, Nofer JR (2007) Apolipoprotein E interrupts interleukin-1β signaling in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 27:1610–1617CrossRefPubMed

29.

Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ (2002) AtheroGene Investigators. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106:24–30CrossRefPubMed

30.

Benetti E, Chiazza F, Patel NS, Collino M (2013) The NLRP3 inflammasome as a novel player of the intercellular crosstalk in metabolic disorders. mediators of inflammation. Mediators Inflamm. doi:10.1155/2013/678627

31.

Oda E, Goto M, Matsushita H, Takarada K, Tomita M, Saito A, Fuse K, Fujita S, Ikeda Y, Kitazawa H, Takahashi M, Sato M, Okabe M, Aizawa Y (2013) The association between obesity and acute myocardial infarction is age- and gender-dependent in a Japanese population. Heart Vessels 28:551–558CrossRefPubMed

32.

Kajiya M, Miyoshi T, Doi M, Usui S, Iwamoto M, Takeda K, Nosaka K, Nakayama R, Hirohata S, Kusachi S, Nakamura K, Ito H (2013) Serum adipocyte fatty acid-binding protein is independently associated with complex coronary lesions in patients with stable coronary artery disease. Heart Vessels 28(6):696–703CrossRefPubMed

33.

Ito H, Motoyama S, Sarai M, Kawai H, Harigaya H, Kan S, Kato S, Anno H, Takahashi H, Naruse H, Ishii J, Narula J, Ozaki Y (2014) Characteristics of plaque progression detected by serial coronary computed tomography angiography. Heart Vessels 29(6):743–749CrossRefPubMed

34.

Takaoka N, Tsujita K, Kaikita K, Hokimoto S, Yamanaga K, Komura N, Chitose T, Ono T, Mizobe M, Horio E, Sato K, Nakayama N, Saito M, Iwashita S, Kojima S, Tayama S, Sugiyama S, Nakamura S, Ogawa H (2014) Intravascular ultrasound morphology of culprit lesions and clinical demographics in patients with acute coronary syndrome in relation to low-density lipoprotein cholesterol levels at onset. Heart Vessels 29(5):584–595CrossRefPubMed

35.

Dominic DN, Eicke L (2011) NLRP3 inflammasome link inflammation and metabolic disease. Trends Immunol 32(8):373–379CrossRef

36.

Shao L, Zhang P, Zhang Y, Lu Q, Ma A (2014) TLR3 and TLR4 as potential clinically biomarkers of cardiovascular risk in coronary artery disease (CAD) patients. Heart Vessels 29(5):690–698CrossRefPubMed

37.

Kang MJ, Homer RJ, Gallo A, Lee CG, Crothers KA, Cho SJ, Rochester C, Cain H, Chupp G, Yoon HJ, Elias JA (2007) IL-18 is induced and IL-18 receptor α plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. J Immunol 178(3):1948–1959CrossRefPubMed

38.

Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum A, Flather MD, Fox KA, GRACE Investigators (2004) A validated prediction model for all forms of acute coronary syndrome. Estimating the risk of 6-month postdischarge death in an international registry. JAMA 291(22):2727–2733CrossRefPubMed

39.

The GRACE investigators (2001) Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalised with acute coronary syndromes. Am Heart J 141(2):190–199CrossRef

40.

Pollack CV Jr, Sites FD, Shofer FS, Sease KL, Hollander JE (2006) Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population. Acad Emerg Med 13(1):13–18CrossRefPubMed

41.

Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E (2000) TIMI Risk Score for ST-Elevation Myocardial Infarction: a Convenient, Bedside, Clinical Score for Risk Assessment at Presentation An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy. Circulation 102(17):2031–2037CrossRefPubMed

42.

Pauwels NS, Bracke KR, Dupont LL, Van Pottelberge GR, Provoost S, Vanden Berghe T, Vandenabeele P, Lambrecht BN, Joos GF, Brusselle GG (2011) Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J 38(5):1019–1028CrossRefPubMed

43.

Maes T, Bracke KR, Vermaelen KY, Demedts IK, Joos GF, Pauwels RA, Brusselle GG (2006) Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. Int Arch Allergy Immunol 141(4):354–368CrossRefPubMed

44.

Qu Y, Franchi L, Nunez G, Dubyak GR (2007) Nonclassical IL-1β secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol 179(3):1913–1925CrossRefPubMed

45.

Mariathasan S, Monack DM (2007) Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 7(1):31–40CrossRefPubMed

46.

Sutterwala FS, Ogura Y, Zamboni DS, Roy CR, Flavell RA (2006) NALP3: a key player in caspase-1 activation. J Endotoxin Res 12(4):251–256CrossRefPubMed

47.

Hou C, Zhao H, Liu L, Li W, Zhou X, Lv Y, Shen X, Liang Z, Cai S, Zou F (2011) High mobility group protein B1 (HMGB1) in asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med 17(7):807–815PubMedPubMedCentral

48.

Mitola S, Belleri M, Urbinati C, Coltrini D, Sparatore B, Pedrazzi M, Melloni E, Presta M (2006) Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol 176(1):12–15CrossRefPubMed

49.

Ong AT, Serruys PW, Mohr FW, Morice MC, Kappetein AP, Holmes DR Jr, Mack MJ, van den Brand M, Morel MA, van Es GA, Kleijne J, Koglin J, Russell ME (2006) The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 151(6):1194–1204CrossRefPubMed

50.

Lansky AJ, Goto K, Cristea E, Fahy M, Parise H, Feit F, Ohman EM, White HD, Alexander KP, Bertrand ME, Desmet W, Hamon M, Mehran R, Moses J, Leon M, Stone GW (2010) Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial. Circ Cardiovasc Interv 3(4):308–316CrossRefPubMed

51.

Rouleau JL, Talajic M, Sussex B, Potvin L, Warnica W, Davies RF, Gardner M, Stewart D, Plante S, Dupuis R, Lauzon C, Ferguson J, Mikes E, Balnozan V, Savard P (1996) Myocardial infarction patients in the 1990s: their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. JACC 27(5):1119–1127CrossRefPubMed

52.

Noda M, Takagi A, Kuwatsuru R, Mitsuhashi N, Kasanuki H (2008) Prognostic significance of multiple-detector computed tomography in conjunction with TIMI risk score for patients with non-ST elevation acute coronary syndrome. Heart Vessels 23(3):161–166CrossRefPubMed

53.

Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, Avezum A, Goodman SG, Flather MD, Anderson FA Jr, Granger CB (2006) Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 333(7578):1091

54.

Squire IB, O’Brien RJ, Demme B, Davies JE, Ng LL (2004) N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Clin Sci 107(3):309–316CrossRefPubMed

55.

Lagerqvist B, Diderholm E, Lindahl B, Husted S, Kontny F, Ståhle E, Swahn E, Venge P, Siegbahn A, Wallentin L (2005) FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease. Heart 91(8):1047–1052CrossRefPubMedPubMedCentral

56.

Maseri A, Rebuzzi AG, Cianflone D (1997) Need for a composite risk stratification of patients with unstable coronary syndromes tailored to clinical practice. Circulation 96(12):4141–4142PubMed

57.

Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock: sHOCK Investigators: should we emergently revascularize occluded coronaries for cardiogenic shock. NEJM 341(9):625–634CrossRefPubMed

58.

Mark DB. Medical economics in cardiovascular medicine. In: Topol EJ, ed. (1998) Textbook of Cardiovascular Medicine 1033–1061

59.

Newby LK, Califf RM, Guerci A, Weaver WD, Col J, Horgan JH, Mark DB, Stebbins A, Van de Werf F, Gore JM, Topol EJ, GUSTO Investigators (1996) Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for OccludedCoronary Arteries (GUSTO) trial. JACC 27(3):625–632CrossRefPubMed

60.

Antman EM, Kuntz KM (2000) The length of the hospital stay after myocardial infarction. NEJM 342:808–810CrossRefPubMed

Titel: Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients
verfasst von: Altaf Afrasyab
Peng Qu
Yang Zhao
Kuang Peng
Hongyan Wang
Dayuan Lou
Nan Niu
Dajun Yuan
Publikationsdatum: 20.08.2015
Verlag: Springer Japan
Erschienen in: Heart and Vessels / Ausgabe 8/2016
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI: https://doi.org/10.1007/s00380-015-0723-8

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2016

Aberrant serum polyunsaturated fatty acids profile is relevant with acute coronary syndrome

Prevalence, implication, and determinants of worsening renal function after surgery for congenital heart disease

Waon therapy attenuates cardiac hypertrophy and promotes myocardial capillary growth in hypertensive rats: a comparative study with fluvastatin

Increased mortality and aggravation of heart failure in liver X receptor-α knockout mice after myocardial infarction